Other authors have reported atypical cases of late onset MEN2-related tumours despite carrying the high-risk RET variant C634 [46,47], highlighting that other factors might modify the natural history of MEN2-related MTC. This evidence concerns the gene RET and medullary thyroid gland carcinoma.